Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / *W EXP 12/18/202
Symbol
TDACW on Nasdaq
Price per share
$0.33
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
7,815,704
Total reported value
$2,367,601
% of total 13F portfolios
0%
Share change
+510,464
Value change
+$151,537
Number of holders
33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 33 institutional investors reported holding 7,815,704 shares of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW).

Institutional Holders of Translational Development Acquisition Corp. - *W EXP 12/18/202 (TDACW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 7,815,704 $2,367,601 +$151,537 $0.31 33
2025 Q3 7,305,240 $2,127,339 +$15,660 $0.29 33
2025 Q2 7,067,786 $1,867,458 +$432,784 $0.25 29
2025 Q1 5,196,582 $954,744 +$954,744 $0.20 21